Chen, Ruilin. “Semaglutide As a Novel Therapeutic Agent for Obesity and Type 2 Diabetes”. Transactions on Materials, Biotechnology and Life Sciences 8 (October 11, 2025): 454–459. Accessed May 16, 2026. https://tmbls.org/index.php/ojs/article/view/73.